Sellas Life Correlations
| SLS Stock | USD 1.41 0.01 0.71% |
The correlation of Sellas Life is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Sellas Life moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Sellas Life Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Average diversification
The correlation between Sellas Life Sciences and NYA is 0.13 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Sellas Life Sciences and NYA in the same portfolio, assuming nothing else is changed.
Sellas |
The ability to find closely correlated positions to Sellas Life could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Sellas Life when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Sellas Life - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Sellas Life Sciences to buy it.
Moving against Sellas Stock
| 0.68 | VERV | Verve Therapeutics | PairCorr |
| 0.64 | VCNX | Vaccinex Trending | PairCorr |
| 0.59 | EQ | Equillium | PairCorr |
| 0.56 | DRTS | Alpha Tau Medical | PairCorr |
| 0.55 | DMTK | DermTech | PairCorr |
| 0.52 | DNTH | Dianthus Therapeutics Symbol Change | PairCorr |
| 0.5 | DRMA | Dermata Therapeutics | PairCorr |
| 0.48 | VANI | Vivani Medical | PairCorr |
| 0.47 | DNLI | Denali Therapeutics | PairCorr |
| 0.46 | DRUG | Bright Minds Biosciences | PairCorr |
| 0.45 | VERA | Vera Therapeutics | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Sellas Stock performing well and Sellas Life Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Sellas Life's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| NLSP | 4.84 | (1.13) | 0.00 | 0.51 | 0.00 | 7.69 | 49.56 | |||
| MREO | 2.98 | (0.05) | 0.00 | (0.43) | 0.00 | 7.09 | 17.85 | |||
| ARAV | 5.97 | (1.72) | 0.00 | (0.79) | 0.00 | 9.09 | 62.58 | |||
| DAWN | 3.24 | (0.32) | 0.00 | (0.22) | 0.00 | 6.30 | 21.23 | |||
| RVPHW | 9.16 | (0.53) | 0.00 | 0.66 | 0.00 | 21.05 | 75.95 | |||
| EYEN | 7.03 | (1.19) | 0.00 | (0.47) | 0.00 | 14.08 | 50.35 | |||
| CGTX | 3.17 | (0.02) | 0.00 | 0.02 | 3.72 | 8.10 | 29.14 | |||
| RNAZ | 7.95 | 2.17 | 0.17 | 0.46 | 10.71 | 28.78 | 99.24 | |||
| KOD | 4.16 | (0.79) | 0.00 | (0.33) | 0.00 | 8.04 | 45.41 | |||
| OCUP | 3.47 | (0.59) | 0.00 | (0.43) | 0.00 | 7.10 | 25.05 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Sellas Life without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Financial Widgets Now
Financial WidgetsEasily integrated Macroaxis content with over 30 different plug-and-play financial widgets |
| All Next | Launch Module |
Sellas Life Corporate Management
Elected by the shareholders, the Sellas Life's board of directors comprises two types of representatives: Sellas Life inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sellas. The board's role is to monitor Sellas Life's management team and ensure that shareholders' interests are well served. Sellas Life's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sellas Life's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Barbara Esq | General VP | Profile | |
| Stacy Yeung | Associate VP | Profile | |
| Jrg Breitkopf | Head Operations | Profile | |
| ScD MD | President, Founder | Profile | |
| Barbara Wood | Gen VP | Profile | |
| Andrew Elnatan | Chemistry, Affairs | Profile | |
| Robert Francomano | Senior Officer | Profile |
Already Invested in Sellas Life Sciences?
The danger of trading Sellas Life Sciences is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Sellas Life is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Sellas Life. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Sellas Life Sciences is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Sellas Life Sciences is a strong investment it is important to analyze Sellas Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Sellas Life's future performance. For an informed investment choice regarding Sellas Stock, refer to the following important reports: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sellas Life Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Complementary Tools for Sellas Stock analysis
When running Sellas Life's price analysis, check to measure Sellas Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sellas Life is operating at the current time. Most of Sellas Life's value examination focuses on studying past and present price action to predict the probability of Sellas Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sellas Life's price. Additionally, you may evaluate how the addition of Sellas Life to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |
Is Sellas Life's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sellas Life. If investors know Sellas will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sellas Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.08) | Quarterly Revenue Growth (0.82) | Return On Assets (0.85) | Return On Equity (3.13) |
The market value of Sellas Life Sciences is measured differently than its book value, which is the value of Sellas that is recorded on the company's balance sheet. Investors also form their own opinion of Sellas Life's value that differs from its market value or its book value, called intrinsic value, which is Sellas Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sellas Life's market value can be influenced by many factors that don't directly affect Sellas Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sellas Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sellas Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sellas Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.